Deoiled Rice Bran
Related Insights
Sulfur and Aluminum Supply at Risk: What the Hormuz Crisis Means for Chemical Procurement
The Strait of Hormuz disruption extends beyond oil markets, affecting sulfur, aluminum, methanol and graphite that support global chemical manufacturing. Procurement teams should reassess sourcing strategies as industrial raw material risks continue to evolve.
Algal Oil and Marine Bio-Based Ingredients: A Hormuz-Independent Supply Strategy for Food Ingredient Buyers
Fermentation-based marine ingredients such as algal DHA, astaxanthin and beta-glucan offer food manufacturers a more resilient supply chain during periods of global shipping disruption. Procurement teams should understand why production geography matters as much as ingredient performance.
Iran’s “Service Fees”: What Toll-Based Passage Would Cost the Chemical Industry Annually
Iran’s proposal to charge “service fees” for Hormuz passage could permanently reshape the economics of global chemical trade. If transit charges become permanent, Gulf-origin chemical supply chains may face $500 million to $1.5 billion in additional annual costs that buyers will ultimately absorb through higher contract pricing.
Commodity Chemical Intelligence: The Kpler 34 Framework for Reading Physical Recovery vs Diplomatic Progress
The most important lesson from 124 days of the 2026 Hormuz crisis is that physical supply recovery and diplomatic progress move independently. For chemical procurement teams planning Q3 supply, vessel crossing data from Kpler now matters far more than political statements coming out of Doha negotiations.
Thailand's Emergency Fuel Export Ban: A Case Study in Downstream Chemical Disruption and Supply Chain Risk
Thailand's emergency fuel export ban highlighted how government intervention can rapidly disrupt downstream chemical supply chains. Procurement teams that rely on Thai petrochemical exports can use this case to strengthen sourcing strategies and reduce exposure to sudden market shocks.
Heparin and Biologics Raw Materials: Supply Chain Review and Procurement Outlook for H2 2026
The biologics supply chain remained resilient through H1 2026 despite higher logistics costs. As heparin production stays concentrated and biologics demand grows, procurement teams should focus on diversification, quality assurance, and long-term supplier partnerships.
Don't miss out on our updates! Subscribe to our newsletter now
We're committed to your privacy. Tradeasia uses the information you provide to us to contact you about our relevant content, products, and services. For more information, check out our privacy policy.